Get instant clarity on your lab results review. We decode complex medical coding terms, clinical documentation, and healthcare data, providing easy-to-understand explanations of your diagnosis. Find information on abnormal lab values, diagnostic tests, and health metrics related to your condition. Understand your healthcare journey with comprehensive and accessible lab results analysis.
Also known as
Abnormal findings on examination
Covers nonspecific abnormal lab results found during examination.
Abnormal findings of function studies
Includes abnormal results from various functional tests and analyses.
Encounters for examinations
Encompasses routine check-ups where lab tests may be reviewed.
Persons encountering health services
Includes follow-up encounters for review of prior lab test results.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is review for abnormal results?
Yes
Is condition active?
No
Routine health screening?
When to use each related code
| Description |
|---|
| Lab Results Review |
| Abnormal Lab Value |
| Hyperlipidemia |
Lack of documentation linking lab results to a definitive diagnosis, impacting accurate ICD-10 coding and reimbursement.
Using unspecified lab procedure codes when more specific LOINC codes are available, leading to claim denials and lost revenue.
Insufficient physician documentation of lab result review, hindering accurate CDI queries and compliance audits for medical necessity.
Lab results review performed for abnormal blood glucose levels. Patient presented with symptoms including polyuria, polydipsia, and polyphagia. Fasting blood glucose was elevated at 132 mgdL, confirming the suspected diagnosis of diabetes mellitus type 2. Hemoglobin A1c was measured at 7.5%, indicating suboptimal glycemic control. Lipid panel revealed elevated triglycerides at 210 mgdL and low HDL cholesterol at 35 mgdL, increasing cardiovascular risk. Basic metabolic panel showed normal electrolyte levels and kidney function. Urinalysis was negative for ketones and protein. Based on these laboratory findings, the diagnosis of type 2 diabetes mellitus is confirmed. Patient education was provided regarding lifestyle modifications, including diet and exercise. Metformin therapy initiated at 500 mg twice daily, with plans to titrate dose based on subsequent blood glucose monitoring. Follow-up appointment scheduled in two weeks to reassess glycemic control and adjust treatment plan as needed. Differential diagnoses considered included type 1 diabetes mellitus and gestational diabetes, but were ruled out based on patient history, physical examination, and laboratory results. ICD-10 code E11.9 for type 2 diabetes mellitus without complications assigned.